S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

CRL Charles River Laboratories International Inc

206.39

0.00 (0.00%)

26 Jun 2024 - Closed

Delayed by 15 minutes

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Charles River Laboratories (NYSE:CRL)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more Charles River Laboratories Charts.

Charles River Laboratories (NYSE:CRL)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more Charles River Laboratories Charts.

Charles River Laboratories International Inc News

Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus
Tuesday 25 June 2024 (20 hours ago) • Business Wire

Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy
Monday 17 June 2024 (1 week ago) • Business Wire

Charles River Laboratories, in Collaboration With MatTek Corporation, Awarded Grant from the Foundation for Chemistry Research and Initiatives to Advance Research Alternatives
Tuesday 11 June 2024 (2 weeks ago) • Business Wire

Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in Somerville
Thursday 6 June 2024 (3 weeks ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 5 June 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 5 June 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 5 June 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 5 June 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 5 June 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 5 June 2024 (3 weeks ago) • Edgar (US Regulatory)

Charles River Laboratories Announces Development of Nonclinical Virtual Control Groups with Sanofi to Reduce the Use of Animals in Research
Tuesday 4 June 2024 (3 weeks ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 4 June 2024 (3 weeks ago) • Edgar (US Regulatory)

More Charles River Laboratories International Inc News Articles

Vontobel Financial Produ...

Vecima Networks

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions